Coronavirus (COVID-19) information for Dana-Farber patients & families Learn more
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions. You may request a live medical interpreter for a discussion about your care.
Dr. Haigis received his PhD from the University of Wisconsin in 2002 and continued training as a postdoctoral fellow in the laboratory of Tyler Jacks at MIT. He became a Harvard Medical School Assistant Professor of Pathology in 2007 and Associate Professor of Medicine in 2014. Additional appointments include Assistant Pathologist at Massachusetts General Hospital (2007-2014); Faculty Member of the HMS Biological and Biomedical Sciences Graduate Program and Full Member of the Gastrointestinal Malignancies Cancer Genetics Program of the DF/HCC (both 2007 – present); Investigator at the Center for the Study of Inflammatory Bowel Disease at MGH/BIDMC (2007-2016); Associate Member of the Center for Systems Biology at MGH (2010-2014); Member of the Harvard Digestive Disease Center and Faculty Member of the Bioinformatics and Integrative Genomics Graduate Program (both 2016- present). He served as Director of Cancer Genetics at Beth Israel Deaconess Cancer Center from 2014 until joining Dana-Farber as Chief Research Officer in 2020. He is an Associate Member of the Broad Institute (2017- present).
Dana-Farber Cancer Institute450 Brookline AvenueMayer MA-0641Boston, MA 02215Get Directions